Schiff base N4O2 complexes offer a flexible template on which to develop no
vel antimalarial drug complexes that inhibit the aggregation of hemozoin, a
detoxification product of the malaria parasite Plasmodium falciparum. The
efficacies of these complexes are dependent on the charges of the complexes
. Further evidence suggests that these complexes inhibit hemozoin formation
via a specific drug/heme propionate salt that prevents the formation of th
e requisite axial propionato linkage in the repeating dimeric unit of the h
emozoin aggregate.
[GRAPHICS]